The purpose of the study is to understand the drug pricing methods used in the international market covering at least 10 countries, including China, Sri Lanka, Bangladesh and the United States.
To make the drug accessible and affordable in India, the Narendra Modi government will begin a survey on drug pricing policies in at least 10 countries, including China, Sri Lanka, Bangladesh and the United States. News18.com Have learned. The Ministry of Chemicals and Fertilizer’s Pharmaceutical Department (DoP) has begun bidding in search of a reputable company that can conduct research on behalf of the government.
The purpose of the study is to understand the drug pricing methods used in the international market, which covers at least 10 countries. It also aims to understand lessons learned and best practices from different countries (or regions) in terms of drug availability and affordability.
NPPA in control
According to the Request for Proposal (RFP) document labeled “Bid Announcement” News18.com, The National Pharmaceuticals Pricing Authority (NPPA), a drug pricing watchdog, wants to ask reputable companies and research institutes to investigate. NPPA is a DoP arm.
The title of the document is “To study drug pricing policies in different countries / regions and lessons learned from these countries / regions regarding access to affordable medicines”.
The deadline for submitting the proposal is February 21st, and finalists will be required to present it on March 1st.
The survey will include secondary sources and the top 10 countries will be selected
According to the document, the government plans to study regulatory policies or frameworks for drug prices in at least 10 countries (or regions) to identify best practices or lessons learned. Apart from studying other policy aspects that affect drug availability and affordability in these countries, it is also possible to study the operational implementation of drug price policies in different countries. I am planning.
“The minimum 10 countries / regions covered are Sri Lanka, Bangladesh, China, EU, United Kingdom, Australia, United States, Brazil, South Africa and Thailand,” the document said.
This research is primarily based on secondary sources of data and other information available in the public domain. We also conduct interviews or focused group discussions (FGDs) with foreign delegations, related trade and industry groups, drug exporters, and foreign manufacturers to elicit feedback and opinions.
According to the 18-page RFP document, the final report after the company’s selection must be submitted within 4 months. “In addition to this, quarterly progress shall be submitted by the applicant until the final submission of the report,” he says.
Read all the latest news, Trend news, Cricket news, Bollywood news,
Indian news When Entertainment news here. Follow us on Facebook, twitter And Instagram.
Central government studying drug prices in 10 countries to make drugs affordable in India
Source link Central government studying drug prices in 10 countries to make drugs affordable in India